James Tannahill is President of Plocamium Holdings, a private equity and specialized services firm. He leads global strategy, investment execution, and operational value creation across healthcare, national security, and industrial packaging sectors.
James previously served as Assistant Vice President of Strategic Finance at Vaxart (Nasdaq: VXRT), leading corporate development and strategic planning. Earlier, he held investment research and product development roles at M Science (NYSE: JEF) and Accrete.ai. He began his career in equity research with a focus on global healthcare. James is also the co-founder of 1nessAgency, specializing in ethical growth strategies for healthcare providers.
James is a partner at Student Sponsor Partners, supporting academically at-risk students in New York City. He is a member of the Young Presidents’ Organization (YPO) and The Economic Club of New York.
James holds an MBA from Cornell University’s SC Johnson College of Business, an M.S. in Biotechnology from the University of Essex, and a B.S. in Biochemistry from Denison University.
Outside of work, James may be found battling the ocean under sail or conducting casual hikes with his partner, Sydney.